Serum Adiponectin Levels Are Positively Associated With Diabetic Peripheral Neuropathy in Chinese Patients With Type 2 Diabetes

Qing Sun,Bin Yan,Dan Yang,Jie Guo,Chao Wang,Qian Zhang,Yue Shi,Xiaohu Shi,Guoqing Tian,Xiaochun Liang
DOI: https://doi.org/10.3389/fendo.2020.567959
IF: 6.055
2020-11-25
Frontiers in Endocrinology
Abstract:Objective To investigate the association between serum adiponectin levels and diabetic peripheral neuropathy (DPN) in Chinese type 2 diabetes (T2D) patients. Design and Methods Two hundred nineteen T2D patients aged 40–79 years were divided into two groups according to whether they had DPN. The systemic levels of five biomarkers were measured using a human adipokine multiplexed bead-based immunoassay. Diabetic peripheral neuropathy diagnostic criteria included both common DPN symptoms and neurological screening tests. Results Most features of DPN ( n =98) and non-DPN patients ( n =121) are similar, but the DPN patients were slightly older, had longer diabetes duration, higher hemoglobin (Hb) A1c, lower estimated glomerular filtration rates (eGFR), less exercise, and used lipid-lowering drugs more often. Serum adiponectin levels of DPN patients were higher than that of non-DPN patients (8.13 vs . 9.63 mg/ml, P = 0.004). Serum adiponectin levels were positively associated with DPN after adjusting for age, gender, body mass index, hypertension, HbA1c, alcohol intake, smoking status, physical activity, log-transformed low density lipoprotein cholesterol, lipid-lowering drug usage, eGFR, and diabetes duration {odds ratio (OR) 1.72 [95% confidence interval (CI) 1.02-2.89], P = 0.041}. The OR refers to a doubling in biomarkers. Conclusions Serum adiponectin levels were higher in DPN patients compared to non‐DPN patients in this Chinese T2D population. Serum adiponectin levels were positively associated with DPN presence, independent of multiple confounders.
endocrinology & metabolism
What problem does this paper attempt to address?
The paper aims to study the correlation between serum adenosine levels and diabetic peripheral neuropathy (DPN) in Chinese patients with type 2 diabetes (T2D). Specifically, the objective of the paper is to investigate the association between serum adenosine levels and diabetic peripheral neuropathy in Chinese patients with type 2 diabetes. The study design included 219 T2D patients aged between 40 and 79 years, who were divided into two groups based on whether they had DPN. The systemic levels of five biomarkers, including adenosine, were measured using multiple immunoassays. The diagnostic criteria included typical DPN symptoms and neurological screening tests. The results of the study indicated that the serum adenosine levels in patients with DPN were significantly higher than those in patients without DPN. This positive correlation remained even after adjusting for various confounding factors such as age, gender, body mass index, hypertension, glycated hemoglobin (HbA1c), alcohol intake, smoking status, physical activity, low-density lipoprotein cholesterol, lipid-lowering medication use, estimated glomerular filtration rate (eGFR), and duration of diabetes. Therefore, the paper concludes that in this Chinese T2D population, serum adenosine levels are higher in patients with DPN compared to those without DPN, and this positive correlation is independent of multiple potential confounding factors.